ACTIVE

REVATIS VET

Export PDF
Financial year 2025 · closed on 31/12/2025
Net result
-112,4 k €
Gross margin
3,2 k €
Equity
483,1 k €

What does REVATIS VET do?

REVATIS VET is a Private limited company incorporated in 2024. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Marche-en-Famenne.

Legal situation
● Normal situation
BCE/KBO no. / VAT
BE 1015.868.627
Incorporation
04/11/2024
Legal form
Private limited company
Registered office
Aye, Rue de la Science 8
6900 Marche-en-Famenne · WallonieSee on map
Contributed capital
595 491,00 €
Latest accounts
31/12/2025
Activities (NACE)
46460Wholesale of pharmaceutical goods· main46460Wholesale of pharmaceutical goods
Signals
Solid equityLow riskGood liquidityPositive cashflowPositive EBITDA
View the BCE/KBO Public Search record →
Health score
Available with a Rovalta subscriptionTry for 7 days
Recommended credit limit
✦ Verdict · Analyst summary
Financials

Trend over 1 financial year

2025
Income statement
Gross margin3,2 k €
EBITDA3,2 k €
Operating result-112,1 k €
Net result-112,4 k €
Balance sheet
Equity483,1 k €
Total assets614,9 k €
Cash71,5 k €
Debts131,5 k €
Estimate

Indicative valuation

As an indication, this company is worth

between 0 € and 100 k€
See the valuation
Governance

Board of directors

Seen on filing of 31/12/2025 · 2 active

Active mandates

Didier SERTEYN

Director · since 04 novembre 2024

Active
SHATAL

Director · since 04 novembre 2024 · 0476.699.768

Active
At this address

Other companies at this address

CompanyCBE no.
AGRICELLS● Active
0742.991.393
Association pour le développement des Productions Agroalimentaires de qualité● Active
0416.914.413
Association pour l'Usage et la Défense de l'Appellation Jambon d'Ardenne● Active
0457.901.762
ASSOCIATION POUR L'USAGE ET LA DEFENSE DU SAUCISSON D'ARDENNE● Active
0863.356.814
ATB THERAPEUTICS● Active
0677.980.015
Bureau d’Administration ATB THERAPEUTICS● Active
1031.100.991
CER-Groupe● Active
0420.654.158
INVESTY CORPORATE● Active
1008.960.841
Orgenesis (Belgium)● Bankrupt
0540.866.555
ORGENESIS SERVICES SRL● Bankrupt
0790.353.624
RevaTis● Active
0541.682.642
THERACELL ADVANCED BIOTECHNOLOGY (Belgium)● Active
0731.712.273
Annual accounts

Full financial information

2025
Type of accountMicro model
Start of the financial year01/11/2024
Closing of the financial year31/12/2025
Length of the financial year14 months
Filing date21/07/2026
General meeting17/06/2026
Currency of the financial yearEUR
NBB quality labelSatisfying controls
Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days
Filings

Annual accounts filings

1 filing with the NBB

ModelClosingGeneral meetingFiledLanguageDocument
Micro model31/12/202517/06/202621/07/2026FrenchPDF
Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 0 € and 100 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 2 active

Active mandates

Didier SERTEYN

Director · since 04 novembre 2024

Active
SHATAL

Director · since 04 novembre 2024 · 0476.699.768

Active
Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days
Belgian Official Gazette

Belgian Official Gazette publications

  • Mandates30/12/2024
    STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …) - CAPITAL, ACTIONS - DEMISSIONS, NOMINATIONS
    PDF
  • Restructuring22/11/2024
    RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...)
    PDF
  • Other06/11/2024
    RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
    PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025-112,4 k €
  2. 04/11/2024
    IncorporationPrivate limited company